Clinical trials
Phase 1 Prostatic Neoplasms trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 7 |
| Active, not recruiting | 6 |
| Terminated | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 5 |
| Janssen Research & Development, LLC | 3 |
| AstraZeneca | 2 |
| Novartis Pharmaceuticals | 2 |
| Advanced Accelerator Applications | 1 |
| Alterome Therapeutics, Inc. | 1 |
| Amgen | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Atavistik Bio, Inc | 1 |
| Blue Earth Therapeutics Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 27 |
| Breast Neoplasms | 7 |
| Neoplasm Metastasis | 7 |
| Neoplasms | 7 |
| Ovarian Neoplasms | 6 |
| Triple Negative Breast Neoplasms | 5 |
| Uterine Cervical Neoplasms | 5 |
| Endometrial Neoplasms | 4 |
| Esophageal Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.